Renaissance Technologies - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$431
-47.8%
139,374
-24.0%
0.00%0.0%
Q2 2023$825
+4.6%
183,300
+32.3%
0.00%0.0%
Q1 2023$789
-4.2%
138,500
+1.5%
0.00%0.0%
Q4 2022$824
-99.9%
136,500
-4.8%
0.00%0.0%
Q3 2022$948,000
+13.1%
143,400
-10.6%
0.00%0.0%
Q2 2022$838,000
+202.5%
160,486
+300.2%
0.00%
Q1 2022$277,000
-82.5%
40,100
-68.5%
0.00%
-100.0%
Q4 2021$1,584,000127,2000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 15,594,877$1,115,813,0009.76%
Baker Brothers Advisors 10,118,636$723,988,0002.73%
Rock Springs Capital Management LP 360,363$25,784,0000.55%
HHLR ADVISORS, LTD. 750,000$53,663,0000.43%
Old Well Partners, LLC 3,450$247,0000.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 111,065$7,947,0000.11%
PERSONAL CFO SOLUTIONS, LLC 4,500$322,0000.08%
ARS Investment Partners, LLC 7,400$529,0000.06%
CAAS CAPITAL MANAGEMENT LP 50,000$3,578,0000.03%
FMR LLC 4,209,963$296,295,0000.03%
View complete list of PRELUDE THERAPEUTICS INC shareholders